These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4633598)

  • 1. Two years' experience with Rh hemolytic disease reporting.
    Hawes WE; Mordaunt VL
    Calif Med; 1973 May; 118(5):28-32. PubMed ID: 4633598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Rh prophylaxis.
    Berger GS; Keith L
    Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune cytopenias in newborns].
    Brossard Y
    Rev Prat; 2001 Sep; 51(14):1571-6. PubMed ID: 11757274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal mortality from Rh(D) hemolytic disease in Finland, 1975-1984.
    Eklund J; Nevanlinna HR
    Acta Obstet Gynecol Scand; 1986; 65(7):787-9. PubMed ID: 3028031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 10. Rh isoimmunization, Manitoba, 1963-75.
    Bowman JM; Chown B; Lewis M; Pollock J
    Can Med Assoc J; 1977 Feb; 116(3):282-4. PubMed ID: 402178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the newborn. A new law for prenatal blood test and disease reporting.
    Saylor LF
    Calif Med; 1970 Feb; 112(2):79. PubMed ID: 4990381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Data on the neonatal mortality due to Rh hemolytic disease (case report from the San Filippo pediatric department of the Galliera hospitals)].
    Sansone G; Moscatelli P; Veneziano G
    Pathologica; 1972; 64(927):55-7. PubMed ID: 4629918
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the newborn due to anti-Di: a case study and review of the literature.
    Mochizuki K; Ohto H; Hirai S; Ujiie N; Amanuma F; Kikuta A; Miura S; Yasuda H; Ishijima A; Suzuki H
    Transfusion; 2006 Mar; 46(3):454-60. PubMed ID: 16533290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of anti-Rho(D) antibody production in Japanese Rho(D)-negative women by Rh incompatibility between mother and fetus, and prognosis of the infants (author's transl)].
    Izawa H; Nishizawa R; Igarashi M
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):201-6. PubMed ID: 6785986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.